Barclays PLC bought a new position in Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 192,354 shares of the biotechnology company’s stock, valued at approximately $3,335,000. Other institutional investors have also recently added to or reduced […]
